Latest News in Pharma industry

AstraZeneca’s Eneboparatide Meets Phase 3 Goals in Hypoparathyroidism Trial with Full Data Pending
Sanofi Acquires Dren Bio’s DR-0201 for $1.9 Billion to Advance Autoimmune Therapies
BioCopy Secures €8M to Accelerate AI-Powered Cancer Drug Discovery
bioMérieux Secures FDA Clearance for VITEK COMPACT PRO, Advancing Rapid Microbial Diagnostics
Maxion Therapeutics Secures $72M Series A to Advance KnotBody Antibody Drugs for Autoimmune and Pain Treatment
Google Unveils TxGemma AI to Accelerate Drug Discovery with Open Models
ELAHERE Improves Survival in Platinum-Resistant Ovarian Cancer AbbVie Releases Final Phase 3 Data
Sanofi Adopts FDA-Approved Flu Strains for 2025-26 Season to Ensure Vaccine Readiness
Trump Confronts Irish Prime Minister Over US Trade Deficit and Pharma Industry Shift
Geron CEO John Scarlett Steps Down as Biotech Firm Shifts Focus to Commercial Growth
Novartis Expands Radiopharmaceutical Investments with $10 Billion Growth Target
Medtronic’s SMART Trial Shows Evolut TAVR Outperforms SAPIEN in Small Aortic Annulus Patients
Bristol Myers Squibb's Sotyktu Shows Strong Phase 3 Results in Psoriatic Arthritis Trial, Eyes Regulatory Approval
Amgen and Kyowa Kirin Report Positive Phase 3 Results for Rocatinlimab in Atopic Dermatitis
Full Circles Therapeutics Secures Key Patent for Non-Viral Genome Editing with Circular DNA
FDA Approves Neffy Needle-Free Epinephrine Spray for Children with Severe Allergies
Needle-Free Vaccine Patch Delivers Stronger Immunity and a Path to the Future
Pharma’s Silent Purge: Are Veteran Scientists Being Replaced for Cheaper Talent?
Lexicon Pharmaceuticals Unveils Trial Results That Could Shake Up the $5 Billion Neuropathic Pain Market
Phase III Study Shows Xolair Outperforms Oral Immunotherapy with Fewer Side Effects in Food Allergy Treatment
Avobis Bio Moves Closer to Breakthrough Treatment for Crohn’s Fistulas with FDA Fast Track Approval
GSK Plans $27 Million CEO Pay Raise While Shares Drop 13 Percent Investors Face a High-Stakes Gamble
The Measles Resurgence: Two Deaths and Counting—Public Health Crisis and Market Implications
Enodia Therapeutics Secures Pfizer’s Golden Ticket With Game-Changing Protein Degradation Tech That Outshines PROTACs
Eli Lilly’s $50 Billion Gamble on U.S. Manufacturing Sparks Cheers, Fears, and Fierce Debate
Ecopipam’s Phase 3 Breakthrough Paves the Way for a New Era in Tourette Syndrome Treatment
Scientific Censorship Wipes Out Critical Data, Pharma Innovation at Risk as U.S. Faces Research Exodus
Hims & Hers Projects $2.3 Billion Revenue Amid Telehealth Growth and Regulatory Uncertainty
Trump’s Upcoming Pharma Tariff Shockwave Disrupts Global Supply Chains and Threatens Drug Prices
Novo Nordisk Ends Wegovy and Ozempic Shortage Sparks a $150 Billion GLP-1 Market Showdown with Eli Lilly
mRNA Vaccine Aftershocks Shake Pharma as Scientists Uncover Persistent Spike Protein and Investor Uncertainty Grows
Variational AI Scores $5.5M to Disrupt Drug Discovery with Generative AI, Challenging Industry Giants
Pfizer Ends Beqvez Development as Gene Therapy Faces Market Reality
Solid Biosciences Stock Skyrockets as Gene Therapy Breakthrough Sparks Investor Frenzy
VIVOZON Secures MFDS Approval for UNAFRA Inj a Game Changer in Non Opioid Pain Relief
Exelixis Shakes Up Kidney Cancer Treatment with Game-Changing Five-Year Data Proving CABOMETYX and Opdivo’s Lasting Survival Edge
Zoetis Wins USDA Approval for H5N2 Avian Influenza Vaccine, Boosting Poultry Industry Hopes
AbbVie’s CEO Shake-Up: Robert A Michael Takes Over as Chairman Amid High-Stakes Industry Challenges
Nexus Pharmaceuticals Wins FDA Approval for Tacrolimus Injection in Breakthrough Single-Dose Vial
From Stealth to $50 Million: How Latent Labs Is Using AI to Redesign Biology and Revolutionize Drug Discovery
Johnson & Johnson Reshapes MedTech with Billion-Dollar Stroke Care Exit
Regeneron’s Eylea HD Phase III Trial Success Signals Breakthrough in Macular Edema Treatment
Teva and Medincell Advance Schizophrenia Treatment with Successful Phase 3 Trial Completion
Japan Faces Vaccine Shortage Disrupting Immunization Plans and Market Stability
eGenesis Achieves Second Successful Pig Kidney Transplant in Major Xenotransplantation Breakthrough
Bain Capital invests $3.3 billion in Japanese pharma firm with 300-year legacy
BioNTech’s Personalized Kidney Cancer Vaccine Shows Promise in Early Trial
Eli Lilly’s 2025 Forecast Sparks Confidence as Weight-Loss Drugs Drive Growth
Ariceum Secures FDA Orphan Drug Status for Cancer Therapy Amid Growing Radiopharmaceutical Race
Qlaris Bio Advances Glaucoma Treatment with Promising Phase II Results
Load More
We use cookies on our website to enable certain functions, to provide more relevant information to you and to optimize your experience on our website. Further information can be found in our Privacy Policy and our Terms of Service . Mandatory information can be found in the legal notice